A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperacti... von Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya A., Liranso, Tesfaye, Odebo, Oyinkansola, Kosheleff, Alisa R., Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Schwabe, Stefan, Childress, Ann

Volltext

Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults von Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Schwabe, Stefan, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi

Volltext

Impact of a High-Fat Meal and Sprinkled Administration on the Bioavailability and Pharmacokinetics of Viloxazine Extended-Release Capsules (QelbreeTM) in Healthy Adult Subjects von Wang, Zhao, Kosheleff, Alisa R, Adeojo, Lilian W, Odebo, Oyinkansola, Liranso, Tesfaye, Schwabe, Stefan, Nasser, Azmi

Volltext

Impact of Paroxetine, a Strong CYP2D6 Inhibitor, on SPN‐812 (Viloxazine Extended‐Release) Pharmacokinetics in Healthy Adults von Wang, Zhao, Kosheleff, Alisa R., Adeojo, Lilian W., Odebo, Oyinkansola, Adewole, Toyin, Qin, Peibing, Maletic, Vladimir, Schwabe, Stefan, Nasser, Azmi

Volltext